PNC Financial Services Group
KRBP

PNC Financial Services Group’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

PNC Financial Services Group’s Portfolio KRBP Stock Details KRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-133
Closed -$724 – 4884
2022
Q4 		$724 Hold
133
– – ﹤0.01% 4456
2022
Q3 		$1K Buy
+133
New +$1.54K ﹤0.01% 4381

Other funds holding KRBP

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PNC Financial Services Group's KRBP Position: Q1 2023 in Review

PNC Financial Services Group sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q1 2023, closing a stake of 133 shares — an estimated $724 sold.

PNC Financial Services Group first reported a position in KRBP in Q3 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 7 funds tracked by Wall St. Rank hold KRBP as of Q1 2023.

  • PNC Financial Services Group reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 133 Kiromic BioPharma, Inc. Common Stock shares in Q1 2023, an estimated $724.
  • PNC Financial Services Group first reported a position in Kiromic BioPharma, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • PNC Financial Services Group's Kiromic BioPharma, Inc. Common Stock position peaked at $1K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.